Global Animal Auto-Immune Disease Diagnostics Market To Generate a Revenue Of $5 billion By 2028

The global animal auto-immune disease diagnostics market was worth around $3.4 billion in 2021 and is predicted to grow to around $5 billion by 2028 at a CAGR rate of 4.2% over the forecast period.

Auto-immune diseases are a flawed condition of the immune system where it fails to identify our own body tissues and starts treating them like antigens. This way it disrupts our own body causing illness. Animals are prone to this condition a lot more than humans. Some of the very common auto-immune diseases are pemphigus conditions, dry eye, or Addison’s disease. Some kind of arthritis or allergies the animal develops also is a reason for auto-immune conditions.

Most of the diagnoses for these auto-immune conditions are done via blood tests. The measurement of all important components and nutrients is devised through blood tests like platelets, red blood cells, and white blood cells. A common test of urinalysis is also conducted for the presence of this condition.

Sometimes these diseases can get lethal or they can even destruct the whole-body metabolism. Humans, when they develop these kinds of conditions, they are tested with the presence of C-reactive proteins or erythrocyte sedimentation rate. The presence of these minerals indicates the presence of the disease or auto-immune conditions. They have to be immediately taken for treatment as some of these diseases could be more lethal or develop into chronic conditions.

Covid-19 had a delirious impact on the global animal auto-immune disease diagnostics market. The supply and demand were interrupted heavily and there was a loss of labor and human resources which hampered the growth. Covid-19 as a disease also had an impact on the market as many healthcare firms focused on the pandemic-infected patients and disregarded other illnesses. Animal health spending had also taken a hit during the pandemic because of curfews and lockdowns. Commutation and travel became an issue and no importance was given to animal welfare, thereby restricting market expansion.

The rising presence of zoonotic diseases in immune-compromised patients and the awareness that comes with developing auto-immune conditions drive market growth. The spread of the HIV virus from animals to humans is also looked at as a probable cause for auto-immune conditions. The consumption of meat has also seen a rise which invariably provokes the need for healthy livestock. These factors augment the growth of the global animal auto-immune disease diagnostics market.

Initiatives and programs headed by government and healthcare organizations are supporting the market as well. These diagnostics are pacy and take lesser time to give the results. The on-spot evaluations from these diagnostics results trigger immense demand from the consumers. There have also been ample technological advancements in the tests and diagnostics which have helped improve efficiency and precision in the tests. All these factors work as the growth drivers of the market substantially.

On the other hand, the high cost associated with the tests and the absence of skilled laborers to perform the test impede the growth of the market. Limited intervention from the government with many regulations on conducting the tests also hamper the market expansion considerably.

The global animal auto-immune disease diagnostics market is fragmented into test type, indication, animal type, end-user, and region. The test type is classified into complete blood count, thyroid test, biopsy test, urinalysis, DNA amplification test, and immunoassays test. Indications are hypothyroidism, pemphigus disease, canine lupus, hemolytic anemia, arthritis, and others. Animal types are dogs, cats, horses, livestock animals, cattle, swine, fish, and sheep. End-users are veterinary hospitals and veterinary clinics.

North America leads the global animal auto-immune disease diagnostics market with the biggest share value due to multiple government-supported programs to aid these diagnostics tests. The meat consumption in this region has improved which induces a great demand for all healthcare reforms for the welfare of animals. The prevalence of auto-immune diseases has given an immense awareness about their effects and impact. Further, constantly improving healthcare reforms and infrastructures to support animal welfare augments market growth in the Asia-Pacific region. Patient needs and healthcare awareness, in general, have become more prominent in these regions that people look forward to beneficial medical procedures.

The key players in the global animal auto-immune disease diagnostic market are Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter Inc., SQI Diagnostics, Quest Diagnostics, EUROMMIUM AG, Inova Diagnostics, Crescendo Bioscience, Bio-Rad laboratories, Hemagem Diagnostics, Progentec, and Thermo Fisher Scientific.

Recent Developments:

• In March 2020, Thermo Fisher Scientific Inc acquired QIAGEN N.V. which is a leading provider of life science solutions. They have a presence in 25 countries and they provide diagnostic solutions across all regions.
• In September 2020, Progentec launched a novel blood test that shows the risk index of autoimmune diseases. It can assess the likelihood of systemic lupus erythematosus in 12 weeks.

Browse the full “Animal Auto-Immune Disease Diagnostics Market, By Test Type (Complete Blood Count, Thyroid Test, Biopsy Test, Urinalysis, DNA Amplification Test, and Immunoassays Test), By Indication (Hypothyroidism, Pemphigus Disease, Canine Lupus, Hemolytic Anemia, Immune-Related Arthritis, and Others), By Animal Type (Dogs, Cats, Horse, Live Stock Animals, Cattle, Swine, Fish, and Sheep), By End-User (Veterinary Hospitals and Veterinary Clinics), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/animal-auto-immune-disease-diagnostics-market

The global animal auto-immune disease diagnostics market is segmented as follows:

By Test Type

• Complete Blood Count
• Thyroid Test
• Biopsy Test
• Urinalysis
• DNA Amplification Test
• Immunoassays Test

By Indication

• Hypothyroidism
• Pemphigus Disease
• Canine Lupus
• Hemolytic Anemia
• Immune-Related Arthritis
• Others

By Animal Type

• Dogs
• Cats
• Horses
• Livestock Animals
• Swine
• Cattle
• Fish
• Sheep

By End-Users

• Veterinary Hospitals
• Veterinary Clinics

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com